Charlotte's Web Holdings (CWBHF) Cash & Equivalents (2020 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Cash & Equivalents came in at $5.2 million in Q1 2026, down 73.15% year-on-year from $19.4 million in Q1 2025, and down 35.31% on a QoQ basis from $8.0 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cash & Equivalents (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 7 years of Cash & Equivalents data on file, last reported at $5.2 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 73.15% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 73.15% decrease from a year earlier, with the FY2025 full-year figure at $8.0 million, down 64.48% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $5.2 million, down from $8.0 million in the prior quarter.
- Over the last five years, Cash & Equivalents for CWBHF reached as high as $67.0 million in Q4 2022 and fell as low as $5.2 million in Q1 2026.
- Historically, Cash & Equivalents has averaged $30.0 million across 5 years, with a median of $22.6 million in 2024.
- Across the five-year window, Cash & Equivalents soared 319.27% in 2023 and slumped 73.15% in 2026, its largest moves.
- Year by year, Cash & Equivalents stood at $67.0 million in 2022, then retreated by 28.59% to $47.8 million in 2023, then tumbled by 52.7% to $22.6 million in 2024, then slumped by 64.48% to $8.0 million in 2025, then plunged by 35.31% to $5.2 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $5.2 million in Q1 2026, $8.0 million in Q4 2025, and $9.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.90 Bn | 648.10 Mn | 1.28 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | 3.97 Mn |
| 7 | Viatris | 20.43 Bn | 18.62 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.81 Bn | 16.49 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | 8.04 Mn |
| Sep 30, 2025 | 9.81 Mn |
| Jun 30, 2025 | 15.27 Mn |
| Mar 31, 2025 | 19.36 Mn |
| Dec 31, 2024 | 22.62 Mn |
| Sep 30, 2024 | 24.62 Mn |
| Jun 30, 2024 | 32.53 Mn |
| Mar 31, 2024 | 38.51 Mn |
| Dec 31, 2023 | 47.82 Mn |
| Sep 30, 2023 | 51.02 Mn |
| Jun 30, 2023 | 61.73 Mn |
| Mar 31, 2023 | 60.78 Mn |
| Dec 31, 2022 | 66.96 Mn |
| Sep 30, 2022 | 16.51 Mn |
| Jun 30, 2022 | 14.82 Mn |
| Mar 31, 2022 | 14.50 Mn |
| Dec 31, 2021 | 19.49 Mn |
| Dec 31, 2020 | 52.80 Mn |